Caremark served as the pharmacy benefit management company for private health plans who insured a number of dual eligibles, and under the law, the private insurer, rather than the government, must assume the costs of healthcare for dual eligibles.
According to the lawsuit filed against Caremark, the company’s RxCLAIM computer platform did not pay the full amount owed on certain claims. The government alleged the platform improperly deducted certain co-payment or deductible amounts when calculating payments, which caused Medicaid to incur the costs for prescription drugs for dual eligibles rather than Caremark-administered private health plans.
The lawsuit was originally filed by a former Caremark employee under the qui tam, or whistle-blower, provision of the False Claims Act.
Although Caremark agreed to settle this case, there has been no admission of guilt.
More articles on healthcare industry lawsuits:
Shire Pharmaceuticals to pay $56.6M to resolve FCA allegations over Adderall marketing
Group of Pennsylvania hospitals sue Highmark over reduced reimbursements
7 latest healthcare industry lawsuits, settlements
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.